EUCTR2014-003155-57-DE进行中（未招募）不适用
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled study to investigate the efficacy and safety of 52 weeks treatment with QGE031 s.c. in Asthma Patients not adequately controlled by medium- or high-dose ICS plus LABA with or without OCS
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 440
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •A diagnosis of allergic asthma, uncontrolled on current medication.
- •History of at least 2 asthma exacerbations during the last 1 year
- •Forced Expiratory Volume in one second (FEV1) of = 40% and = 80%
- •of the predicted normal value; reversibility following administration of
- •bronchodilator.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 293
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 147
排除标准
- •Use of tobacco products within the previous 6 months (Social occasional smokers may be included).
- •Recent asthma attack/exacerbation or asthma worsening/ respiratory
研究者
相似试验
进行中（未招募）
不适用
A Multi-Center, Randomized, Double-Blind, Placebo-controlled Study of Adalimumab in Japanese Subjects with Moderately to Severely Active Ulcerative ColitisEUCTR2014-004559-29-Outside-EU/EEAAbbVie Inc.274
进行中（未招募）
1 期
Efficacy and safety of QGE031 versus placebo in patients aged 18-75 years with asthma not adequately controlled with standard of care medication (inhaled corticosteroids plus long lasting beta agonists with or without oral corticosteroids)Severe AsthmaMedDRA version: 18.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2014-003155-57-GBovartis Pharma Services AG10
进行中（未招募）
1 期
Efficacy and Safety of BMS-986165 versus Placebo and Active Comparator in Subjects with PsoriasisModerate-to-Severe Plaque PsoriasisMedDRA version: 20.0Level: LLTClassification code 10071117Term: Plaque psoriasisSystem Organ Class: 100000004858EUCTR2018-001926-25-PLBristol-Myers Squibb International Corporation600
进行中（未招募）
不适用
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group StudyComparing SYR-322 Alone and Combination SYR-322 with Pioglitazone versus Placebo on Postprandial Lipids in Subjects with Type 2 Diabetes - Post-PrandialEUCTR2007-000486-38-NLTakeda Global Research & Development Centre (Europe) Ltd.,71
进行中（未招募）
1 期
Phase 3 trial of PXT3003 in Charcot-Marie-Tooth (CMT) Type 1A patientsCharcot Marie Tooth Type 1AMedDRA version: 20.0Level: LLTClassification code 10008414Term: Charcot-Marie-Tooth diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-004805-30-DKPharnext SCA387